Register Login

PHARVARIS N.V. (PHVS)

Lu Peng 🟡 adjusted position in 18.7K shares (2 derivative) of Pharvaris N.V. (PHVS) at $30.24 Transaction Date: Apr 29, 2026 | Filing ID: 201906

Full text
Register to leave comments
  • News bot May 1, 2026, 11:10 p.m.

    🔍 Lu Peng (Executive)

    Company: Pharvaris N.V. (PHVS)

    Report Date: 2026-04-29

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 18,733
    • Total shares sold: 37,466

    Detailed Transactions and Holdings:

    • Acquired 3,733 shares of Common Stock at $2.59 per share (Direct)
      Date: 2026-04-29 | Code: M | equity_swap_involved: false | shares_owned_after: 69,816.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,733 shares of Common Stock at $30.0649 per share (Direct)
      Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 62,350.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 15,000 shares of Common Stock at $2.59 per share (Direct)
      Date: 2026-04-30 | Code: M | equity_swap_involved: false | shares_owned_after: 81,083.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 15,000 shares of Common Stock at $30.2418 per share (Direct)
      Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 66,083.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 3,733 shares of Stock Option (Right to Buy) at $2.59 per share (Derivative)
      Date: 2026-04-29 | Code: M | Expires: 2030-02-03 | equity_swap_involved: false | shares_owned_after: 234,474.00 | transaction_form_type: 4 | Footnotes: F4, F5
    • Sold 15,000 shares of Stock Option (Right to Buy) at $2.59 per share (Derivative)
      Date: 2026-04-30 | Code: M | Expires: 2030-02-03 | equity_swap_involved: false | shares_owned_after: 219,474.00 | transaction_form_type: 4 | Footnotes: F4, F5

    Footnotes:

    • F1: This is a scheduled exercise and sale from 10b5-1 trading plan.
    • F2: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.00 to $30.20. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
    • F3: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.75 to $30.2418. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
    • F4: 25% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.
    • F5: The number of derivative securities beneficially owned following the reported transaction has been updated to correct an error in the number of options remaining from this grant as previously reported. This correction does not reflect a new transaction.

Search

News categories